Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pre-CIN: NSAID and steroid regimens to prevent inflammation and cystoid macular edema after cataract surgery
2020-003407-34Phase 4Active
- Sponsor
- Oslo University Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nepafenac and HiDex in senile cataract (ARC) (3 arms), sponsored by Oslo University Hospital. Primary endpoint: Laser flare. Started Mar 2021; status: active.
02
Drugs
nepafenacHiDex
03
Conditions
senile cataract (ARC)
Beyond the preview
Go deeper on 2020-003407-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003407-34.